These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7035043)
1. Paradoxical behaviour of antithrombin III during hemodialysis and its prevention with prostacyclin. Turney JH; Fewell M; Williams LC; Dodd N; Weston MJ Clin Nephrol; 1982 Jan; 17(1):31-5. PubMed ID: 7035043 [No Abstract] [Full Text] [Related]
6. Hemodialysis with the stable prostacyclin analogue CG 4203. Maurin N Prog Clin Biol Res; 1987; 242():479-84. PubMed ID: 3313422 [No Abstract] [Full Text] [Related]
7. Controlled study of heparin versus epoprostenol sodium (prostacyclin) as the sole anticoagulant for chronic hemodialysis. Caruana RJ; Smith MC; Clyne D; Crow JW; Zinn JM; Diehl JH Blood Purif; 1991; 9(5-6):296-304. PubMed ID: 1819317 [TBL] [Abstract][Full Text] [Related]
8. Prostacyclin substitution for heparin in long-term hemodialysis. Smith MC; Danviriyasup K; Crow JW; Cato AE; Park GD; Hassid A; Dunn MJ Am J Med; 1982 Nov; 73(5):669-78. PubMed ID: 6753575 [TBL] [Abstract][Full Text] [Related]
9. Prostacyclin as the sole antithrombotic agent for acute renal failure hemodialysis. Hory B; Saint-Hillier Y; Perol JC Nephron; 1983; 33(1):71. PubMed ID: 6339968 [No Abstract] [Full Text] [Related]
10. [Use of prostaglandins in extracorporeal circulation and hemodialysis]. Zaorska B Pol Tyg Lek; 1981 Jun; 36(23):857-60. PubMed ID: 7024949 [No Abstract] [Full Text] [Related]
11. Safety and efficacy of epoprostenol (PGI2) versus heparin (H) in hemodialysis (HD). Dubrow A; Flamenbaum W; Mittman N; Hall J; Zinn J Trans Am Soc Artif Intern Organs; 1984; 30():52-4. PubMed ID: 6398552 [No Abstract] [Full Text] [Related]
12. Effects of prostacyclin during cardiopulmonary bypass in man. Rådegran K; Egberg N; Papaconstantinou C Scand J Thorac Cardiovasc Surg; 1981; 15(3):263-8. PubMed ID: 6753137 [No Abstract] [Full Text] [Related]
13. [Effect of heparin in uremic patients during hemodialysis]. Cullmann W; Glöckner WM; Müller N Fortschr Med; 1981 Mar; 99(12):410-2. PubMed ID: 7227936 [TBL] [Abstract][Full Text] [Related]
14. [Antithrombin III deficiency: when substitute, when heparin? Thrombosis ABC, 3: The role of antithrombin III]. Stiefelhagen P MMW Fortschr Med; 1999 Sep; 141(37):41. PubMed ID: 10897973 [No Abstract] [Full Text] [Related]
15. [Prostaglandin for prevention of blood coagulation due to hemodialysis]. Kitazawa K; Kobayashi K; Sugisaki T Nihon Rinsho; 1991 Dec; 49 Suppl():753-7. PubMed ID: 1808346 [No Abstract] [Full Text] [Related]
17. Antithrombin III supplementation allowed haemodialysis without heparin after kidney transplantation. Nicastro MA; Plana JL; Heller MV; Dorado EG; Zucchini A; Molinas FC Nephrol Dial Transplant; 1993; 8(11):1281-2. PubMed ID: 8302472 [No Abstract] [Full Text] [Related]
18. A new prostacyclin analogue - an anticoagulant applicable to hemodialysis. Ota K; Kawaguchi H; Takahashi K; Ito K Trans Am Soc Artif Intern Organs; 1983; 29():419-24. PubMed ID: 6369729 [No Abstract] [Full Text] [Related]
20. The transient transfer of plasma antithrombin-III to an extraplasmatic body compartment during haemodialysis. Jespersen J Thromb Res; 1981 Jun 1-25; 22(5-6):693-6. PubMed ID: 7302912 [No Abstract] [Full Text] [Related] [Next] [New Search]